Sozen, S. Et Al. 2005. Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study. EUROPEAN UROLOGY , vol.47, no.3 , 302-307.

Sozen, S., ESKICORAPCI, S. Y., Kupelia, B., Irkilata, L., ALTINEL, M., Ozer, G., ... Uygur, C.(2005). Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study. EUROPEAN UROLOGY , vol.47, no.3, 302-307.

Sozen, S Et Al. "Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study," EUROPEAN UROLOGY , vol.47, no.3, 302-307, 2005

Sozen, S Et Al. "Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study." EUROPEAN UROLOGY , vol.47, no.3, pp.302-307, 2005

Sozen, S. Et Al. (2005) . "Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study." EUROPEAN UROLOGY , vol.47, no.3, pp.302-307.

@article{article, author={S Sozen Et Al. }, title={Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study}, journal={EUROPEAN UROLOGY}, year=2005, pages={302-307} }